Effect of drug-loaded TiO2 nanotube arrays on osseointegration in an orthodontic miniscrew: an in-vivo pilot study

Osseointegration was evaluated for the surface of miniscrews with TiO2 nanotube arrays containing drugs in this in-vivo study. The diameter and length of the TiO2 nanotube arrays were about 70 nm and 5 mu m, respectively. Recombinant human bone morphogenetic protein-2 (rhBMP-2) or ibuprofen was loaded in the TiO2 nanotube arrays with 12 miniscrews. The 12 drug-loaded miniscrews, 6 miniscrews with no drug-loaded TiO2 nanotube arrays and 6 conventional miniscrews, were placed on the tibias of New Zealand white rabbits. Histological osseointegration was assessed 8 weeks after implantation by measuring the bone-to-implant contact (BIC) ratio. Ibuprofen-loaded miniscrews showed a significantly higher BIC of 71.6% over conventional miniscrews of 44.3% on average. The mean BIC ratios of rhBMP-2-loaded miniscrews and no drug-loaded miniscrews was 24.6% and 60.1%, respectively. Our results suggest that TiO2 nanotube arrays on the surface of miniscrews could be used as carriers of drugs, and loading ibuprofen in TiO2 nanotube arrays may improve osseointegration of miniscrews. However, the effect of rhBMP-2 loaded in TiO2 nanotube arrays on osseointegration of miniscrews was questionable in this pilot study.